Raymond James Financial Services Advisors’s Apyx Medical APYX Stock Holding History

Raymond James Financial Services Advisors’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$107K	Buy	86,609 +2,086	+2%	+$2.63K	﹤0.01%	3283
2024 Q2	$113K	Sell	84,523 -200	-0.2%	-$295	﹤0.01%	3212
2024 Q1	$115K	Sell	84,723 -523,905	-86%	-$1.11M	﹤0.01%	3202
2023 Q4	$1.59M	Buy	608,628 +187,350	+44%	+$454K	﹤0.01%	1699
2023 Q3	$1.35M	Buy	421,278 +1,100	+0.3%	+$5.13K	﹤0.01%	1745
2023 Q2	$2.11M	Buy	420,178 +27,351	+7%	+$139K	﹤0.01%	1482
2023 Q1	$1.13M	Buy	392,827 +34,090	+10%	+$99.5K	﹤0.01%	1830
2022 Q4	$839K	Sell	358,737 -50,373	-12%	-$154K	﹤0.01%	1950
2022 Q3	$1.84M	Buy	409,110 +33,492	+9%	+$240K	﹤0.01%	1464
2022 Q2	$2.2M	Buy	375,618 +73,012	+24%	+$375K	﹤0.01%	1384
2022 Q1	$1.98M	Buy	302,606 +6,150	+2%	+$60.6K	﹤0.01%	1496
2021 Q4	$3.8M	Buy	296,456 +8,984	+3%	+$126K	0.01%	1148
2021 Q3	$3.98M	Buy	287,472 +7,069	+3%	+$74.4K	0.01%	1095
2021 Q2	$2.89M	Buy	280,403 +5,185	+2%	+$51.4K	0.01%	1263
2021 Q1	$2.66M	Buy	275,218 +10,663	+4%	+$107K	0.01%	1235
2020 Q4	$1.91M	Buy	264,555 +7,245	+3%	+$48K	﹤0.01%	1327
2020 Q3	$1.21M	Sell	257,310 -17,264	-6%	-$85.5K	﹤0.01%	1434
2020 Q2	$1.52M	Buy	274,574 +16,000	+6%	+$66.5K	﹤0.01%	1239
2020 Q1	$928K	Buy	258,574 +10,100	+4%	+$67.8K	﹤0.01%	1240
2019 Q4	$2.1M	Sell	248,474 -10,275	-4%	-$74.2K	0.01%	1144
2019 Q3	$1.75M	Buy	258,749 +13,314	+5%	+$94.5K	0.01%	1177
2019 Q2	$1.65M	Buy	245,435 +18,401	+8%	+$100K	0.01%	1208
2019 Q1	$1.43M	Buy	227,034 +3,300	+1%	+$25.5K	0.01%	1248
2018 Q4	$1.45M	Sell	223,734 -6,600	-3%	-$40K	0.01%	1071
2018 Q3	$1.64M	Buy	230,334 +82,984	+56%	+$461K	0.01%	1191
2018 Q2	$641K	Buy	147,350 +46,600	+46%	+$172K	﹤0.01%	1699
2018 Q1	$299K	Sell	100,750 -15,500	-13%	-$39.9K	﹤0.01%	2032
2017 Q4	$302K	Buy	116,250 +6,300	+6%	+$19.7K	﹤0.01%	2017
2017 Q3	$372K	Buy	109,950 +29,200	+36%	+$75.4K	﹤0.01%	1900
2017 Q2	$199K	Buy	+80,750	New	+$198K	﹤0.01%	2235